Literature DB >> 11543663

Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines.

M Fukuda1, K Ikuta, K Yanagihara, M Tajima, H Kuratsune, T Kurata, T Sairenji.   

Abstract

Transforming growth factor (TGF)-beta1 is a multifunctional cytokine that plays important roles in regulating cell growth and differentiation in many biological systems. In this study, we found that gastric tissue-derived Epstein-Barr virus (EBV)-infected epithelial cell lines GT38 and GT39 had resistance to TGF-beta1-mediated growth inhibition and apoptosis compared to a TGF-beta1-susceptible gastric carcinoma cell line HSC-39. However, TGF-beta1 partially induced EBV reactivation in GT38 and GT39 cells, as shown by the induction of EBV immediate-early BZLF1 RNA and its protein product ZEBRA and early antigen-D. The expressions of TGF-beta receptor I and II were detected in GT38 and GT39 cells by Northern and Western blot analyses. Both cell lines spontaneously produced the TGF-beta1, which was sufficient for inhibiting cell growth of HSC-39 cells. Taken together, these data suggest that TGF-beta1 may be a key factor for EBV reactivation and selective growth of EBV-infected epithelial cells in vivo. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543663     DOI: 10.1006/viro.2001.1071

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus.

Authors:  Richard J Kraus; Jacqueline G Perrigoue; Janet E Mertz
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Downregulates GCNT3 via the TGF-β1/Smad-mTORC1 Signaling Axis.

Authors:  Juanjuan Liu; Yan Zhang; Caixia Yu; Jun Li; Wen Liu; Bing Luo
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

3.  Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Reovirus activates transforming growth factor beta and bone morphogenetic protein signaling pathways in the central nervous system that contribute to neuronal survival following infection.

Authors:  J David Beckham; Kathryn Tuttle; Kenneth L Tyler
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

5.  Preventive effect of hydrotalcite on gastric mucosal injury in rats induced by taurocholate.

Authors:  Bao-Ping Yu; Jun Sun; Mu-Qi Li; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

6.  Identification of a negative regulatory element in the Epstein-Barr virus Zta transactivation domain that is regulated by the cell cycle control factors c-Myc and E2F1.

Authors:  Zhen Lin; Qinyan Yin; Erik Flemington
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  Makoto Fukuda; Richard Longnecker
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Transforming growth factor-beta-mediated regulation of BK virus gene expression.

Authors:  Johanna R Abend; Michael J Imperiale
Journal:  Virology       Date:  2008-06-17       Impact factor: 3.616

9.  Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A.

Authors:  Xishuang Liu; Yu Gao; Bing Luo; Youan Zhao
Journal:  Gastroenterol Res Pract       Date:  2011-08-16       Impact factor: 2.260

10.  Methylation and Expression of Retinoblastoma and Transforming Growth Factor-β1 Genes in Epstein-Barr Virus-Associated and -Negative Gastric Carcinomas.

Authors:  Xia Liu; Xiuming Tang; Shaoyan Zhang; Yun Wang; Xiaofeng Wang; Chengquan Zhao; Bing Luo
Journal:  Gastroenterol Res Pract       Date:  2012-09-12       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.